In this video, Erika P. Hamilton, MD, discusses results from the HER2CLIMB-05 trial of tucatinib in combination with ...
In this video from ASCO Annual Meeting, Andrew J. Armstrong, MD, MS, discusses final results of the phase 2 CHAMP trial ...
The FDA’s approval of inebilizumab has heralded a new era for patients with IgG4-related disease, while novel agents moving ...
Vindico Medical Education, a CME platform that delivers high-quality content for health care professionals, has partnered ...
The CDC has officially ended its response to the deadly hantavirus outbreak that triggered federal quarantines of American ...
In this video, Shimoli Barot, MD, discusses results from the phase 3 lidERA BC clinical trial, which assessed efficacy and ...
A growing body of evidence suggests sensitive skin syndrome is a distinct condition driven by impaired neurosensory and ...
With roles as a clinician, professor, researcher, director and company founder, Ruchi Gupta, MD, MPH, has a lot to juggle — ...
The examination revealed a mildly fussy baby with normal vital signs. The only other positive finding was a somewhat ...
More than half of patients with tardive dyskinesia who used valbenazine experienced symptomatic remission at 48 weeks, and ...
The FDA cleared Be Free Day toric contact lenses for the correction of myopia and other refractive errors, according to a ...
The FDA approved another over-the-counter intranasal naloxone product as an emergency treatment for opioid overdoses, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results